[NBIX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
29-Jul-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 150.27%
YoY- 968.22%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 378,200 288,900 302,400 183,580 96,905 6,335 0 -
PBT -23,300 57,500 83,200 52,091 -5,913 -59,985 -40,280 -8.71%
Tax -6,400 15,200 3,600 753 7,591 4,767 -1,548 26.67%
NP -16,900 42,300 79,600 51,338 -5,913 -59,985 -40,280 -13.47%
Tax Rate - -26.43% -4.33% -1.45% - - - -
Total Cost 395,100 246,600 222,800 132,242 102,818 66,320 40,280 46.28%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -4.47 14.64 26.32 27.96 -6.10 -946.88 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.18 0.45 0.86 0.56 -0.07 -0.68 -0.46 -14.47%
EPS Diluted -0.18 0.43 0.81 0.54 -0.07 -0.68 -0.46 -14.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.